Iradimed Corp (IRMD)

EBITDA Growth

15.09%

TTM · Period ending:

IRMD logo

IRMD EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported15.09%
IRMD TTM EBITDA YoY % (9.87% → 15.09%)
High-resolution chart · PNG

IRMD ebitda growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Iradimed Corp EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
15.0906%
22.7022%
17.6714%
14.1324%
9.8512%
9.9069%
13.2309%
20.4894%
33.031%
33.5866%
31.5083%
24.1348%
21.5677%
38.8904%
49.8067%
86.9936%
135.2233%
684.9516%
1,830.3477%
313.6986%
64.017%
-82.6166%
-94.2703%
-78.2316%
-52.5451%
22.0332%
43.068%
51.772%
56.3985%
115.3128%
283.3417%
206.5189%
21.6355%
-52.4475%
-83.3037%
-83.8927%
-68.1564%
-42.8366%
-5.37%
50.5874%
135.1438%
176.6468%
265.0789%
132.1639%
59.0343%
66.7415%
9.8651%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.